As Ebola outbreak spreads in Congo, concern grows over supplies of experimental vaccine

Should the outbreak spread more widely in cities, the scale of the outbreak could tax the available supplies of an experimental vaccine being used to help contain spread, said Peter Salama, who heads the World Health Organization’s (WHO) emergencies program.

Ebola vaccine technology could speed up development of other vaccines

In addition to an Ebola vaccine, the Coalition for Epidemic Preparedness Innovations is currently funding the development of vaccines for Lassa fever, Middle East respiratory syndrome, Nipah virus, and coronavirus at the Jenner Institute; and by using the same technology as the Ebola vaccine — called viral vectors — researchers can significantly reduce the time it takes to develop vaccines.